F16.251
Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F16.251 refers to a condition where an individual develops a dependence on hallucinogenic substances, accompanied by a hallucinogen-induced psychotic disorder characterized by hallucinations. This condition involves both substance dependency and mental health symptoms, requiring comprehensive understanding to ensure appropriate management and support.
Causes & Symptoms
Clinical Causes: Repeated use of hallucinogenic drugs such as LSD, psilocybin mushrooms, or mescaline Prolonged or high-dose usage of hallucinogens leading to dependency Genetic predisposition affecting how the brain responds to hallucinogens Underlying mental health problems that may increase susceptibility Use of hallucinogens in settings that encourage continued consumption
Key Symptoms: Visual or auditory hallucinations that are vivid and persistent Altered perceptions of reality, time, and sensory experiences Dependence behaviors, such as craving and compulsive use Psychotic episodes with disorganized thoughts or delusions Anxiety, paranoia, or agitation during psychotic episodes Potential depressive or manic symptoms following drug use
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough clinical interview, review of medical history, and assessment of substance use patterns. Healthcare providers may use specific psychological tests to evaluate the presence and severity of hallucinations and psychosis. Laboratory tests are not definitive but can help rule out other underlying conditions. Diagnostic criteria include evidence of dependence on hallucinogens and the presence of hallucination-induced psychotic episodes.
Treatment Protocols: Detoxification under medical supervision to manage withdrawal symptoms Psychotherapy, such as cognitive-behavioral therapy (CBT), to help modify dependence behaviors and cope with hallucinations Medication management, which may involve antipsychotic drugs to control hallucinations and psychosis Support groups and rehabilitation programs to promote recovery and prevent relapse Education about the effects of hallucinogens to inform better decision-making
Clinical Advice & FAQs
Billing Guidance
Is F16.251 a billable ICD-10 code?
Yes, F16.251 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.251?
Clinical documentation must specify the nature of Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference